Table 2.
Gross target volume (GTV) at presentation and last CBCT with percent of change.
| Pathology subtype | Volume at presentation | Volume at last CBCT | Absolute change (cc) | Percentage (%) | Volume |
|---|---|---|---|---|---|
| MLS | 840 | 600 | −240 | −29 | Decrease |
| Synovial | 120 | 90 | −30 | −25 | Decrease |
| MLS | 530 | 400 | −130 | −24 | Decrease |
| MPNST | 980 | 750 | −230 | −23 | Decrease |
| MLS | 768 | 630 | −138 | −18 | Decrease |
| MPNST | 150 | 130 | −20 | −13 | Decrease |
| Leiomyosarcoma | 90 | 80 | −10 | −11 | Decrease |
| MLS | 360 | 350 | −10 | −2 | Decrease |
| Dedifferentiated liposarcoma | 1125 | 1125 | 0 | 0 | Same |
| Synovial | 410 | 410 | 0 | 0 | Same |
| Dedifferentiated liposarcoma | 430 | 430 | 0 | 0 | Same |
| Dedifferentiated liposarcoma | 1600 | 1600 | 0 | 0 | Same |
| MLS | 1120 | 1120 | 0 | 0 | Same |
| MPNST | 55 | 55 | 0 | 0 | Same |
| Dedifferentiated liposarcoma | 1320 | 1320 | 0 | 0 | Same |
| MLS | 800 | 800 | 0 | 0 | Same |
| Leiomyosarcoma | 290 | 290 | 0 | 0 | Same |
| UPS | 210 | 230 | 20 | 10 | Increase |
| Spindle cell | 4000 | 4400 | 400 | 10 | Increase |
| UPS | 135 | 150 | 15 | 11 | Increase |
| MPNST | 710 | 810 | 100 | 14 | Increase |
| Dedifferentiated liposarcoma | 750 | 900 | 150 | 20 | Increase |
| Dedifferentiated liposarcoma | 1875 | 2350 | 475 | 25 | Increase |
MLS, myxoid liposarcoma; MPNST, malignant peripheral nerve sheath tumor; UPS, undifferentiated pleomorphic sarcoma.